tiprankstipranks
Trending News
More News >
Evelo Biosciences Inc (EVLO)
OTHER OTC:EVLO
US Market

Evelo Biosciences (EVLO) Income Statement

Compare
213 Followers

Evelo Biosciences Income Statement

Last quarter (Q3 2023), Evelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Evelo Biosciences's net income was $-12.36M. See Evelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 108.47M$ 115.40M$ 91.89M$ 86.36M$ 58.10M
Depreciation and Amortization
$ 2.06M$ 2.22M$ 2.03M$ 1.76K$ 1.94K
EBITDA
$ -106.34M$ -115.40M$ -89.86M$ -84.42M$ -58.10M
Operating Income
$ -108.47M$ -115.40M$ -91.89M$ -86.36M$ -58.10M
Other Income/Expenses
$ -5.13M$ -6.35M$ -1.37M$ 885.00K$ 1.16M
Pretax Income
$ -113.60M$ -121.75M$ -93.26M$ -85.47M$ -56.95M
Net Income
$ -114.53M$ -122.18M$ -93.67M$ -85.66M$ -53.85M
Per Share Metrics
Basic EPS
$ -26.28$ -46.18$ -47.45$ -53.49$ -49.25
Diluted EPS
$ -26.28$ -46.18$ -47.45$ -53.49$ -49.25
Weighted Average Shares Outstanding
4.36M 2.65M 1.97M 1.60M 1.09M
Weighted Average Shares Outstanding (Diluted)
4.36M 2.65M 1.97M 1.60M 1.09M
Currency in USD

Evelo Biosciences Earnings and Revenue History